CHILDREN'S TYLENOL PLUS COUGH & RUNNY NOSE OTC
Generic Name and Formulations:
Acetaminophen 160mg, chlorpheniramine maleate 1mg, dextromethorphan HBr 5mg; per 5mL; liq; cherry flavor.
McNeil Consumer Healthcare
Indications for CHILDREN'S TYLENOL PLUS COUGH & RUNNY NOSE:
Rhinorrhea, cough, sore throat, fever, headache, minor aches and pains.
<4yrs (<36lbs): do not use. 4–5yrs (36–47lbs): not recommended. 6–11yrs (48–95lbs): 10mL every 4 hours as needed; max 5 doses/24 hours.
Children <4yrs old (<36lbs). During or within 14 days of MAOIs. Concomitant other acetaminophen products. For use as a sedative hypnotic.
Hepatic dysfunction. Glaucoma. GI or GU obstruction. Asthma. Lower respiratory disorders.
Analgesic + antihistamine + antitussive.
See Contraindications. Hypertensive crisis with MAOIs. Increased CNS effects with other CNS depressants.
Drowsiness, anticholinergic effects, excitability, hepatotoxicity (overdosage).
Clinical Pain Advisor Articles
- Opioid Use Disorders: Advances in Pharmacotherapy Provide Long-term Results
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Women Frequently Prescribed High Doses of Opioids After Vaginal Delivery
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- A Physician's Guide to Incorporating Patient Spirituality in Practice
- FDA Taps Social Media to Identify and Assess Emerging Drug Abuse Threats
- Buffered Lidocaine May Be Superior to Nonbuffered Lidocaine for Inferior Alveolar Nerve Block
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Marijuana's Uncertain Status: Closing the Gap Between State and Federal Policies